CLINICAL_TRIALS
trial_result
· 2014-03-20
Clinical Trial Update: Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML) [Phase 2]
Summary
This clinical trial update reports Phase 2 results for decitabine in patients with chronic myelomonocytic leukemia (CMML).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED